Trial intelligence / Profile preview

Shen Qi Tiao Ti Formula in Polycystic Ovary Syndrome

NCT03623451Unknown

Sponsor
Heilongjiang University of Chinese Medicine
Start
Aug 2018
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of Shen Qi Tiao Ti Formula in polycystic ovary syndrome (PCOS), sponsored by Heilongjiang University of Chinese Medicine. Primary endpoint: Fatty acid amides metabolite changes at 3 months. Status: unknown.

02

Drugs

Shen Qi Tiao Ti Formula
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT03623451.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03623451.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call